Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Global insurers feel the pain from COVID-19 as claims pile up, WSJ says » 13:51
05/14/20
05/14
13:51
05/14/20
13:51
PUK

Prudential plc

$25.53 /

-0.82 (-3.11%)

, RE

Everest Re

$163.44 /

-0.74 (-0.45%)

, SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Global insurers are…

Global insurers are feeling the impact of the coronavirus as claims increase related to event cancellations and postponements amid their other lines of business and are revising their previous profitability views for 2020, reports the Wall Street Journal's Julie Steinberg. "German reinsurance company Munich Re AG last week said it had notched $979M in claims related to the virus, with event cancellations and postponements contributing the bulk," added the Wall Street Journal story. Companies in the space include: Prudential plc (PUK), Everest Re (RE) Swiss Re (SSREY). Reference Link

ShowHide Related Items >><<
RE Everest Re
$163.44 /

-0.74 (-0.45%)

PUK Prudential plc
$25.53 /

-0.82 (-3.11%)

PUK Prudential plc
$25.53 /

-0.82 (-3.11%)

04/21/20 JPMorgan
Prudential plc price target lowered to 1,031 GBp from 1,425 GBp at JPMorgan
04/20/20 HSBC
Prudential plc downgraded to Hold from Buy at HSBC
04/20/20 HSBC
Prudential plc downgraded to Hold from Buy at HSBC
03/12/20 JPMorgan
JPMorgan backs Neutral on Prudential plc after FY19 results
RE Everest Re
$163.44 /

-0.74 (-0.45%)

04/02/20 Keefe Bruyette
Everest Re upgraded to Outperform from Market Perform at Keefe Bruyette
01/21/20 Citi
Everest Re initiated with a Neutral at Citi
SSREY Swiss Re
$0.00 /

+ (+0.00%)

05/04/20 Deutsche Bank
Swiss Re price target lowered to CHF 90 from CHF 100 at Deutsche Bank
05/01/20 UBS
Swiss Re price target raised to CHF 93 from CHF 90 at UBS
04/17/20 Exane BNP Paribas
Swiss Re downgraded to Underperform from Neutral at Exane BNP Paribas
04/09/20 JPMorgan
Swiss Re price target lowered to CHF 98 from CHF 108 at JPMorgan
RE Everest Re
$163.44 /

-0.74 (-0.45%)

SSREY Swiss Re
$0.00 /

+ (+0.00%)

PUK Prudential plc
$25.53 /

-0.82 (-3.11%)

SSREY Swiss Re
$0.00 /

+ (+0.00%)

Recommendations
Swiss Re price target lowered to CHF 90 from CHF 100 at Deutsche Bank » 12:26
05/04/20
05/04
12:26
05/04/20
12:26
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Deutsche Bank analyst Hadley Cohen lowered the firm's price target on Swiss Re to CHF 90 from CHF 100 and keeps a Hold rating on the shares.

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

05/01/20 UBS
Swiss Re price target raised to CHF 93 from CHF 90 at UBS
04/17/20 Exane BNP Paribas
Swiss Re downgraded to Underperform from Neutral at Exane BNP Paribas
04/09/20 JPMorgan
Swiss Re price target lowered to CHF 98 from CHF 108 at JPMorgan
03/31/20 UBS
Swiss Re upgraded to Buy from Sell at UBS
Over a month ago
Recommendations
Swiss Re price target raised to CHF 93 from CHF 90 at UBS » 11:55
05/01/20
05/01
11:55
05/01/20
11:55
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

UBS analyst Jonny Urwin…

UBS analyst Jonny Urwin raised the firm's price target on Swiss Re to CHF 93 from CHF 90 and keeps a Buy rating on the shares.

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

04/17/20 Exane BNP Paribas
Swiss Re downgraded to Underperform from Neutral at Exane BNP Paribas
04/09/20 JPMorgan
Swiss Re price target lowered to CHF 98 from CHF 108 at JPMorgan
03/31/20 UBS
Swiss Re upgraded to Buy from Sell at UBS
12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
Downgrade
Swiss Re downgraded to Underperform from Neutral at Exane BNP Paribas » 06:23
04/17/20
04/17
06:23
04/17/20
06:23
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Paris Hadjiantonis downgraded Swiss Re to Underperform from Neutral with a CHF 75 price target.

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

04/09/20 JPMorgan
Swiss Re price target lowered to CHF 98 from CHF 108 at JPMorgan
03/31/20 UBS
Swiss Re upgraded to Buy from Sell at UBS
12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
Recommendations
Swiss Re price target lowered to CHF 98 from CHF 108 at JPMorgan » 13:41
04/09/20
04/09
13:41
04/09/20
13:41
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

JPMorgan analyst Edward…

JPMorgan analyst Edward Morris lowered the firm's price target on Swiss Re to CHF 98 from CHF 108 and keeps an Overweight rating on the shares. The analyst noted in a European Reinsurance note that COVID-19 is "a material uncertainty for the claims outlook."

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

03/31/20 UBS
Swiss Re upgraded to Buy from Sell at UBS
12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
Upgrade
Swiss Re upgraded to Buy from Sell at UBS » 04:48
03/31/20
03/31
04:48
03/31/20
04:48
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

UBS double upgraded Swiss…

UBS double upgraded Swiss Re to Buy from Sell with a price target of CHF 90, up from CHF 88.50.

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
Over a quarter ago
On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:47
03/02/20
03/02
16:47
03/02/20
16:47
TWTR

Twitter

$35.81 /

+2.62 (+7.89%)

, AAPL

Apple

$298.84 /

+24.2 (+8.81%)

, NXPI

NXP Semiconductors

$120.23 /

+6.54 (+5.75%)

, FTSV

Forty Seven

$93.88 /

+35.88 (+61.86%)

, GILD

Gilead

$75.40 /

+6.03 (+8.69%)

, GE

General Electric

$11.22 /

+0.12 (+1.08%)

, UBS

UBS

$11.26 /

+0.26 (+2.36%)

, SSREY

Swiss Re

$0.00 /

+ (+0.00%)

, CVX

Chevron

$96.57 /

+3.24 (+3.47%)

, KPTI

Karyopharm

$27.82 /

+11.53 (+70.78%)

, CODX

Co-Diagnostics

$17.81 /

+4.69 (+35.75%)

, NVAX

Novavax

$12.04 /

-3.58 (-22.92%)

, GTT

GTT Communications

$14.01 /

-1.045 (-6.94%)

Stocks bounced back after…

Open Full Text

ShowHide Related Items >><<
TWTR Twitter
$35.81 /

+2.62 (+7.89%)

03/03/20 Jefferies
Booking, Expedia, TripAdvisor price targets lowered at Jefferies
03/02/20
Fly Intel: Top five analyst upgrades
03/02/20 Evercore ISI
Evercore upgrades Twitter to In Line after reports of Elliott's involvement
03/02/20 Evercore ISI
Twitter upgraded to In Line from Underperform at Evercore ISI
AAPL Apple
$298.84 /

+24.2 (+8.81%)

03/03/20 Wedbush
Apple's 5G super cycle thesis still well intact, says Wedbush
03/01/20 Oppenheimer
Oppenheimer upgrades 'recurring revenue machine' Apple after selloff
03/01/20 Oppenheimer
Apple upgraded to Outperform from Perform at Oppenheimer
02/27/20 Morgan Stanley
Morgan Stanley sees opportunities for legacy automakers to take share from Tesla
NXPI NXP Semiconductors
$120.23 /

+6.54 (+5.75%)

03/03/20 Mizuho
Mizuho a buyer of NXP Semiconductors on 'muted' coronavirus impact
03/02/20 Oppenheimer
Coronavirus impact on NXP Semiconductors transitory, says Oppenheimer
03/02/20 Bernstein
NXP Semiconductors guidance cut could have been worse, says Bernstein
02/10/20 SunTrust
NXP Semiconductors price target raised to $148 from $139 at SunTrust
FTSV Forty Seven
$93.88 /

+35.88 (+61.86%)

03/03/20 Canaccord
Forty Seven downgraded to Hold from Buy at Canaccord
03/03/20 SunTrust
Forty Seven downgraded to Hold from Buy at SunTrust
03/03/20 Morgan Stanley
Forty Seven downgraded to Equal Weight from Overweight at Morgan Stanley
03/02/20 H.C. Wainwright
Forty Seven downgraded to Neutral from Buy at H.C. Wainwright
GILD Gilead
$75.40 /

+6.03 (+8.69%)

03/02/20 Roth Capital
Forty Seven downgraded to Neutral from Buy at Roth Capital
02/28/20 Benchmark
Ligand a 'coronavirus play in the making,' says Benchmark
GE General Electric
$11.22 /

+0.12 (+1.08%)

03/02/20 Morgan Stanley
GE cash story 'solid' and set to improve, says Morgan Stanley
03/02/20 JPMorgan
'We were wrong,' says JPMorgan's Tusa when upgrading GE to Neutral
03/02/20 JPMorgan
General Electric upgraded to Neutral from Underweight at JPMorgan
UBS UBS
$11.26 /

+0.26 (+2.36%)

10/22/19 Evercore ISI
Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative
10/22/19 Evercore ISI
UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI
09/10/19 Kepler Cheuvreux
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
Fly Intel: Top analyst downgrade
SSREY Swiss Re
$0.00 /

+ (+0.00%)

12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
CVX Chevron
$96.57 /

+3.24 (+3.47%)

02/27/20 Jefferies
Chevron pullback presents attractive entry point, says Jefferies
02/03/20 Credit Suisse
Chevron price target lowered to $128 from $135 at Credit Suisse
01/23/20
Fly Intel: Top five analyst upgrades
01/23/20 Scotiabank
Chevron upgraded to Outperform from Sector Perform at Scotiabank
KPTI Karyopharm
$27.82 /

+11.53 (+70.78%)

03/03/20 Canaccord
Karyopharm price target raised to $35 from $22 at Canaccord
03/02/20 Wedbush
Karyopharm price target raised to $25 from $19 at Wedbush
03/02/20 H.C. Wainwright
Karyopharm price target raised to $43 from $40 at H.C. Wainwright
03/02/20 SVB Leerink
Karyopharm price target raised to $30 from $22 at SVB Leerink
CODX Co-Diagnostics
$17.81 /

+4.69 (+35.75%)

03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
03/03/20 Maxim
Co-Diagnostics downgraded to Hold from Buy at Maxim
02/24/20 H.C. Wainwright
Co-Diagnostics price target raised to $4 from $2 at H.C. Wainwright
03/11/19 H.C. Wainwright
Co-Diagnostics initiated with a Buy at H.C. Wainwright
NVAX Novavax
$12.04 /

-3.58 (-22.92%)

02/28/20 B. Riley FBR
Novavax price target raised to $15 from $12 at B. Riley FBR
02/26/20 Ladenburg
Investors right to buy up Novavax today on COVID-19 plans, says Ladenburg
01/27/20 Ladenburg
Novavax platform ideally suited for pandemic flu outbreaks, says Ladenburg
01/22/20 H.C. Wainwright
Novavax coronavirus results could be catalyst in Q1, says H.C. Wainwright
GTT GTT Communications
$14.01 /

-1.045 (-6.94%)

11/25/19 Cowen
GTT Communications downgraded to Market Perform from Outperform at Cowen
11/13/19 BWS Financial
BWS drops coverage of GTT Communications, sees risk of zero equity value
08/12/19 Raymond James
Raymond James downgrades GTT Communications on salesforce uncertainty
08/12/19 Raymond James
GTT Communications downgraded to Market Perform at Raymond James
  • 04
    Mar
Periodicals
UBS CEO set to become chairman of Swiss Re, Reuters says » 13:38
03/02/20
03/02
13:38
03/02/20
13:38
UBS

UBS

$11.03 /

+0.03 (+0.27%)

, SSREY

Swiss Re

$0.00 /

+ (+0.00%)

UBS (UBS) CEO Sergio…

UBS (UBS) CEO Sergio Ermotti, who will be leaving as the head of Switzerland's biggest bank later this year, is set to become chairman of Swiss Re (SSREY) next year, according to Reuters, citing three people familiar with the matter. Reference Link

ShowHide Related Items >><<
UBS UBS
$11.03 /

+0.03 (+0.27%)

10/22/19 Evercore ISI
Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative
10/22/19 Evercore ISI
UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI
09/10/19 Kepler Cheuvreux
UBS upgraded to Buy from Hold at Kepler Cheuvreux
08/30/19
Fly Intel: Top analyst downgrade
SSREY Swiss Re
$0.00 /

+ (+0.00%)

12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
Conference/Events
Citigroup to hold a conference » 08:06
01/09/20
01/09
08:06
01/09/20
08:06
AEG

Aegon

$4.48 /

+0.045 (+1.02%)

, AVVIY

Aviva

$0.00 /

+ (+0.00%)

, AXA

Ticker AXAHY

$0.00 /

+ (+0.00%)

, PRU

Prudential

$93.99 /

+0.63 (+0.67%)

, SSREY

Swiss Re

$0.00 /

+ (+0.00%)

, SWSDF

Swiss Life

$0.00 /

+ (+0.00%)

, ZURVY

Zurich Insurance

$0.00 /

+ (+0.00%)

European Insurance…

European Insurance Conference will be held in London, England on January 9.

ShowHide Related Items >><<
AEG Aegon
$4.48 /

+0.045 (+1.02%)

10/11/19 Keefe Bruyette
Aegon downgraded to Underperform from Market Perform at Keefe Bruyette
06/10/19 Citi
Aegon upgraded to Neutral from Sell at Citi
05/28/19 Keefe Bruyette
Aegon upgraded to Market Perform from Underperform at Keefe Bruyette
05/21/19 ING Bank
Aegon upgraded to Buy from Hold at ING Group
AVVIY Aviva
$0.00 /

+ (+0.00%)

12/04/19 Barclays
Aviva downgraded to Equal Weight from Overweight at Barclays
11/26/19 Citi
Aviva downgraded to Neutral from Buy at Citi
11/22/19 JPMorgan
Aviva downgraded to Neutral from Overweight at JPMorgan
11/20/19 Deutsche Bank
Aviva downgraded to Hold from Buy at Deutsche Bank
AXA Ticker AXAHY
$0.00 /

+ (+0.00%)

PRU Prudential
$93.99 /

+0.63 (+0.67%)

01/02/20 JPMorgan
JPMorgan cautious on life insurance sector in 2020
11/25/19
Fly Intel: Top five analyst downgrades
11/25/19 Citi
Citi downgrades Prudential to Sell, cuts price target to $86
11/25/19 Citi
Prudential downgraded to Sell from Neutral at Citi
SSREY Swiss Re
$0.00 /

+ (+0.00%)

12/16/19 Exane BNP Paribas
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas
05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank
SWSDF Swiss Life
$0.00 /

+ (+0.00%)

10/23/19 BofA
Swiss Life downgraded to Underperform from Neutral at BofA/Merrill
09/16/19 JPMorgan
Swiss Life downgraded to Underweight from Neutral at JPMorgan
07/01/19 UBS
Swiss Life downgraded to Neutral from Buy at UBS
ZURVY Zurich Insurance
$0.00 /

+ (+0.00%)

12/04/19 Barclays
Zurich Insurance upgraded to Overweight from Equal Weight at Barclays
11/20/19 Jefferies
Zurich Insurance downgraded to Hold from Buy at Jefferies
08/20/19 Jefferies
Zurich Insurance upgraded to Buy from Hold at Jefferies
06/20/19 JPMorgan
Zurich Insurance upgraded to Overweight from Neutral at JPMorgan
Downgrade
Swiss Re downgraded to Neutral from Outperform at Exane BNP Paribas » 05:41
12/16/19
12/16
05:41
12/16/19
05:41
SSREY

Swiss Re

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Exane BNP Paribas analyst Paris Hadjiantonis downgraded Swiss Re to Neutral from Outperform with a CHF 115 price target.

ShowHide Related Items >><<
SSREY Swiss Re
$0.00 /

+ (+0.00%)

05/06/19 Deutsche Bank
Swiss Re downgraded to Hold from Buy at Deutsche Bank

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.